Norris Perne & French LLP MI purchased a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,246 shares of the company's stock, valued at approximately $1,053,000.
A number of other large investors also recently modified their holdings of PG. Signaturefd LLC increased its holdings in shares of Procter & Gamble by 14.4% in the third quarter. Signaturefd LLC now owns 80,702 shares of the company's stock valued at $11,724,000 after purchasing an additional 10,178 shares in the last quarter. Bond & Devick Financial Network Inc. boosted its stake in Procter & Gamble by 5.3% during the 3rd quarter. Bond & Devick Financial Network Inc. now owns 7,562 shares of the company's stock worth $1,099,000 after acquiring an additional 381 shares during the last quarter. McGuire Investment Group LLC increased its stake in Procter & Gamble by 9.3% in the third quarter. McGuire Investment Group LLC now owns 2,937 shares of the company's stock valued at $427,000 after purchasing an additional 250 shares in the last quarter. Simplicity Wealth LLC raised its holdings in Procter & Gamble by 3.5% in the third quarter. Simplicity Wealth LLC now owns 66,516 shares of the company's stock worth $9,664,000 after purchasing an additional 2,224 shares during the period. Finally, Brookmont Capital Management raised its holdings in Procter & Gamble by 34.4% in the third quarter. Brookmont Capital Management now owns 32,483 shares of the company's stock worth $4,719,000 after purchasing an additional 8,309 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on PG shares. BNP Paribas Exane boosted their price target on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an "outperform" rating in a report on Friday. The Goldman Sachs Group reaffirmed a "neutral" rating and set a $161.00 price objective on shares of Procter & Gamble in a research note on Thursday. BMO Capital Markets lifted their target price on Procter & Gamble from $169.00 to $170.00 and gave the stock an "outperform" rating in a report on Monday, June 29th. Morgan Stanley lifted their target price on Procter & Gamble from $166.00 to $185.00 and gave the stock an "overweight" rating in a report on Friday. Finally, Barclays increased their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 21st. Fifteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus target price of $168.90.
View Our Latest Stock Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at approximately $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the transaction, the chief accounting officer owned 1,271 shares of the company's stock, valued at approximately $184,600.04. The trade was a 22.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 15,135 shares of company stock valued at $2,189,970 over the last ninety days. Company insiders own 0.23% of the company's stock.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
- Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
- Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
- Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
- Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook
Procter & Gamble Trading Down 2.6%
PG opened at $161.21 on Friday. The stock has a market capitalization of $374.43 billion, a P/E ratio of 24.28, a P/E/G ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The firm's fifty day simple moving average is $148.41 and its 200 day simple moving average is $147.09. The company has a current ratio of 0.72, a quick ratio of 0.47 and a debt-to-equity ratio of 0.40.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The company's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.99 EPS. As a group, research analysts anticipate that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's payout ratio is 65.51%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.